Total Raised
$81.29MInvestors Count
29Sonus Pharmaceuticals Funding, Sonus Pharmaceuticals Valuation & Sonus Pharmaceuticals Revenue
7 Fundings
Sonus Pharmaceuticals's latest funding round was a Acquired for on August 18, 2008.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
8/18/2008 | Acquired | |||||
10/24/2005 | Corporate Minority | |||||
8/19/2005 | Unattributed VC - IV | |||||
5/6/2004 | Private Equity | |||||
7/7/2003 | Unattributed VC - III |
Date | 8/18/2008 | 10/24/2005 | 8/19/2005 | 5/6/2004 | 7/7/2003 |
|---|---|---|---|---|---|
Round | Acquired | Corporate Minority | Unattributed VC - IV | Private Equity | Unattributed VC - III |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources |
Sonus Pharmaceuticals Investors
29 Investors
Sonus Pharmaceuticals has 29 investors. OncoGenex Pharmaceuticals invested in Sonus Pharmaceuticals's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/18/2008 | 8/18/2008 | 1 Acquired | Corporation | Washington | ||
10/24/2005 | 10/24/2005 | 1 Corporate Minority | Corporation | Germany | ||
10/24/2005 | 10/24/2005 | 1 Corporate Minority | Corporation | New Jersey | ||
Venture Capital | New Jersey | |||||
Venture Capital | Massachusetts |
First funding | 8/18/2008 | 10/24/2005 | 10/24/2005 | ||
|---|---|---|---|---|---|
Last Funding | 8/18/2008 | 10/24/2005 | 10/24/2005 | ||
Investor | |||||
Rounds | 1 Acquired | 1 Corporate Minority | 1 Corporate Minority | ||
Board Seats | |||||
Type | Corporation | Corporation | Corporation | Venture Capital | Venture Capital |
Location | Washington | Germany | New Jersey | New Jersey | Massachusetts |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.